Abstract
Background Digital devices have become a major aspect of children’s life. Associations between screen time and mental health have been observed, but the causality remains unclear. This study aimed to investigate the associations between excessive screen time and later depressive symptoms, and to test the robustness of these associations when accounting for genetic confounding.
Methods This study used data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective cohort of children born between 1991 and 1992 in the UK. Different forms of screen time and depressive symptoms at ages 16, 22 and 26 were assessed through self-completion questionnaires. Screen time > 2 hours per day was defined as excessive. Depressive symptoms at age 26 were measured using the Short Mood and Feelings Questionnaire (SMFQ). Polygenic scores for mental health problems were calculated. Linear regression models were used to examine the associations between screen time at ages 16, 22 and 26 and depressive symptoms at age 26, adjusting for sociodemographic confounders and polygenic scores. Genetic sensitivity analysis (Gsens) was used to test for genetic confounding in these associations.
Results A total of 3,005 participants were included in analysis. Some, but not all, forms of excessive screen time were associated with higher SMFQ scores, e.g. more than 2 hours of television time per day at age 16 (β: 0.07 [95%CI 0.04, 0.11] for weekdays; β: 0.06 [0.02, 0.09] for weekends) and more than 2 hours of gaming time at age 22 (β: 0.07 [95%CI 0.03, 0.10] for weekdays; β: 0.07 [0.04, 0.11] for weekends). These associations persisted after adjusting for sociodemographic confounders and polygenic scores but were attenuated to the null in the genetic sensitivity analysis (β=0.02 [-0.02, 0.06] for the association with >2 hours of television time at age 16 on weekdays; β=-0.01 [-0.05, 0.03]) for >2 hours of gaming time at age 22 on weekdays).
Conclusions For most measures of screen time, there were no associations with depressive symptoms. Where associations were seen, they were completely attenuated in genetic sensitivity analysis, implying genetic confounding is present in the relationship between excessive screen time and depressive symptoms in adolescents and young adults.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and will serve as guarantors for the contents of this paper. This study was supported by the Medical Research Council (MRC) Integrative Epidemiology Unit (MC_UU_00032/7). Annie Herbert was supported by the Wellcome Trust (Grant ref: 224114/Z/21/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for data collection and the use of data by approved researchers was obtained from participants in accordance with the recommendations of the ALSPAC Ethics and Law Committee at the time. Consent for the collection of biological samples was obtained in accordance with the Human Tissue Act [29]. Full details of ethics committee approval references for ALSPAC can be found online at http://www.bristol.ac.uk/alspac/researchers/research-ethics/.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
